Celesq® Programs

Navigating Patent Thickets in BPCIA Litigation

Active
Program Number
29208
Program Date
2019-11-18

Extensive patent portfolios, frequently described as thickets, cover biologic drug products and serve as significant barriers to entry for companies seeking to market follow-on products. Those companies must make a number of strategic choices as they work within a complicated statutory scheme to position themselves for patent litigation that will determine when they can launch their products. This program will examine the lessons learned from litigations brought pursuant to the Biologics Price Competition and Innovation Act and the strategies that companies are pursuing to streamline litigation, navigate the patent thicket, and get to market faster.

Available in States

  • California
  • Georgia
  • New Jersey
  • New York
  • Texas Self Study

Program Categories

  • Administrative Law & Regulations
  • Complex Litigation
  • Federal Courts
  • In-House Counsel
  • Legal Writing
  • Litigation & Litigation Skills
  • Patent Law
  • Pharmaceutical Law
  • Trial Skills